Pharmaceutical firms suffer poor Q1 results
Published: 2011-05-18 07:00:00
Updated: 2011-05-18 07:00:00
A total of KOSPI-listed 33 Korean pharmaceutical companies saw their first-quarter revenues worsen sharply, buffeted by dramatic changes in the business environment such as regulations by the government, conflicts among drug manufacturers, doctors and pharmacists and intense competition among gen...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.